How to Respond to an Unsolicited Offer for Your Veterinary Practice in 2026

Key takeaways

• Take the call — sign nothing. Respond warmly to any buyer’s outreach. Decline to execute any document — NDA, LOI, or exclusivity — until you have spoken with an advisor and understand what your practice is actually worth.
• A direct offer is almost never the best number available. Direct, single-bidder offers reliably come in lower than what the same practice clears when multiple qualified buyers are competing in parallel. The gap is consistently significant on any meaningful practice.
• The LOI exclusivity clause is the most dangerous document in this process. It is the only legally binding provision in a Letter of Intent — and once you sign it, you cannot approach other buyers for 60 to 90 days. That window is where your leverage disappears.
• Get an independent valuation before you evaluate any offer. Without knowing your practice’s normalized EBITDA — what it earns in operating profit after stripping personal expenses — and current market multiples, you have no basis to judge whether the offer is fair, low, or remarkable.
• The playbook is: no exclusivity, get a valuation, create competition. This is the consistent pattern that separates the owners who leave money on the table from the ones who don’t.

The call comes in on a Tuesday afternoon. The person on the other end introduces themselves as part of an acquisition team.

They like what they’ve heard about your practice. They think it might be a good fit.

They have numbers in mind. Could you find 30 minutes to talk?

Most vets freeze on that call. Some get excited.

Some panic. What almost none of them do — at least not without coaching — is follow the disciplined playbook that turns that call from a low-leverage moment into a high-leverage one.

An unsolicited offer is an acquisition approach a buyer initiates without you having formally listed the practice or run a sale process. They found you, they want you, and they’ve arrived with a number before you had a chance to build any alternatives.

That’s the whole dynamic you need to understand — and reverse.

I’ve watched this play out across enough practices to stop calling it a pattern and start calling it a rule. The call itself is not your problem.

What you do in the next 30 to 90 days is everything. This article is the playbook.

---

What is an unsolicited offer for a veterinary practice — and why are you getting one in 2026?

An unsolicited offer is an acquisition inquiry that arrives before you have formally decided to sell. The buyer reaches out directly — by email, phone, letter, or through a local contact — and expresses interest in acquiring your practice.

Nothing about the inquiry obligates you to sell. But it does mean a buyer has identified your practice as a target.

In 2026, these approaches are arriving with renewed frequency. Capstone Partners‘ April 2026 Pet Sector M&A Update reported 18 announced or completed pet-sector transactions year-to-date in 2026, compared to just 8 in the same period of 2025 — deal activity more than doubled in a single year. Strategic buyer activity climbed from 3 transactions to 10 over the same comparison period. PE-backed buyers are actively deploying capital after a period of relative restraint, and multi-doctor general practices in growing markets are precisely the asset class they are competing for.

You are receiving an unsolicited offer because your practice looks attractive from the outside. That is good information.

But the offer itself tells you only that demand exists — not what the full extent of that demand would produce if you put the practice through a proper process.

---

Why an unsolicited offer is almost always a starting point, not the outcome

The most important thing I can tell you about an unsolicited offer is structural: the buyer who contacts you directly is not bringing you their best number.

They are bringing you a number calibrated to your perceived alternatives — which, at the moment they call, are zero. They know you haven’t run a process.

They know you haven’t talked to 10 other buyers. They know the most likely outcome, if you decline, is that nothing changes for you.

A single bidder in a single conversation prices to that reality.

The math on the gap is real. A direct, single-bidder approach reflects what one buyer thinks they need to offer to win exclusively — before they know anyone else is competing. A competitive process, where a curated set of qualified buyers bids against each other with full knowledge that other bids are coming, produces an entirely different number.

The gap between those two outcomes on a meaningful practice is consistently in the millions, not the hundreds of thousands.

This is not a theoretical construct. dvm360 has documented the dynamic: having an organized process with multiple buyers gives you the optionality to pick the deal structure you want, the price you want, and who you’re selling to. That optionality does not exist when you are working with one buyer in a bilateral negotiation.

You are not doing anything wrong by taking the buyer’s call. You are doing something wrong only if you let the urgency of their approach — and there is always urgency built into a direct approach — cause you to skip the steps that protect your outcome.

---

How to respond to an unsolicited offer for your veterinary practice in 2026: the seven-step playbook

Step 1: Take the call — and reveal nothing that commits you

The first conversation is reconnaissance, not negotiation. When the acquisition team calls, pick up. Be warm.

Be curious. Learn what they know about your practice, what buyer type they represent, what kind of transaction they typically do, and roughly what timeline they have in mind.

Do not share detailed financials. Do not confirm or deny any revenue or profitability figures they quote back to you.

Do not let the conversation feel like a negotiation — because it isn’t one yet. You are listening.

Most importantly: do not agree to a follow-up call with a commitment to produce financial documentation. “I appreciate the interest, and I’ll give it some thought” is the right close for an initial call. Nothing more.

Step 2: Get an independent practice valuation before you evaluate anything

You cannot evaluate an offer you don’t have a basis to compare. The number the buyer quotes on a first call is their anchor. Without your own number, their anchor becomes yours.

Normalized EBITDA is what your practice earns in pure operating profit, before taxes and accounting depreciation, after stripping out personal expenses you run through the practice: vehicles, family on payroll above market rate, your own compensation above what a hired medical director would cost. That normalized number is what buyers actually pay multiples on.

Understanding it — and understanding what a reasonable multiple on that number looks like in 2026 — gives you the benchmark you need to evaluate any offer.

A valuation also reveals leverage points: practice characteristics that move the multiple up. Size, revenue concentration, associate independence from the owner-doctor, geographic market, and EBITDA margin all move where a practice lands on the range.

You want to know those before you sit across from a buyer.

Step 3: Understand the full offer structure — not just the headline

This is where most owners get ambushed. The headline number on an initial acquisition approach is rarely the number that arrives in your account after closing.

The difference comes from deal structure.

A typical PE-backed offer in this market allocates the majority of total deal value to cash at closing, with the remainder split across earnout provisions, rollover equity, and in some cases a holdback — a portion of the price the buyer retains after closing, held by the buyer directly and wired to you later if no indemnification claims are made during the holdback period.

Earnout is the part of the sale price paid later — only if the practice hits agreed performance targets after closing. Rollover equity means keeping a slice of ownership in the acquiring entity instead of taking all cash at close. Both are legitimate structures, but both add conditionality and timing risk to the headline number.

The questions to ask about any initial offer:

• How much is guaranteed cash at closing?
• What are the earnout triggers, and over what period?
• What is the holdback percentage and its release timeline?
• What does the employment agreement look like (duration, compensation, clinical expectations)?
• What is the non-compete scope?

Each of those variables can shift the effective value of the deal by hundreds of thousands of dollars. A $5 million headline number with a 25 percent holdback, a 3-year earnout tied to targets the buyer controls the denominator on, and a 5-year non-compete covering your county is a materially different deal than a $5 million headline number with 90 percent cash at close.

Step 4: Do not sign exclusivity — this is the most important step

The LOI exclusivity clause is a provision that legally prevents you from speaking with, soliciting, or entertaining offers from other buyers during a defined period. It is typically the only binding provision in an otherwise non-binding Letter of Intent, and the buyer will push hard to get you to sign it as quickly as possible.

There is a reason they want it fast.

Once you sign exclusivity, you are legally barred from approaching other buyers for 60 to 90 days. The buyer knows this.

They move into the exclusivity window with every informational advantage and every structural advantage. If due diligence surfaces anything they don’t like, some buyers use that window to re-trade the price — revising terms downward at a moment when your alternatives are, legally, zero.

This practice is documented in veterinary M&A literature precisely because it happens.

The right move: do not sign exclusivity until you have run a market check and understand your options. You are not obligated to sign it to keep the conversation alive. A motivated buyer will continue to engage without exclusivity for a reasonable period.

A buyer who tells you the deal dies if you don’t sign exclusivity in 48 hours is a buyer using urgency as a tool, not a reflection of any real market deadline.

The LOI is also not a formality. Non-binding terms anchor the purchase agreement negotiation — buyers resist changing terms they already got you to agree to, even if you later realize those terms were unfavorable. M&A counsel should review the full LOI before you sign anything.

Per Mahan Law’s analysis of veterinary practice LOIs, even non-binding provisions can create implied obligations when ambiguously drafted, opening the door to disputes.

Step 5: Run a competitive process before you commit to any single buyer

A competitive process is a structured sale in which multiple qualified buyers — PE-backed groups, strategic buyers, sometimes individual operators — are invited to review the same information at the same time and submit bids in parallel. The defining feature is that every bidder knows there are other bidders.

That knowledge does the work. When a buyer knows they are competing, they bring their real number — not the opening position they use in a direct conversation.

When there are 5 to 10 serious buyers at the table, the ceiling on the price moves, the terms tighten, and you gain the power to choose based on the full offer, not just the best offer you happened to receive first.

The Elite Selling System we use at Transitions Elite is built around exactly this dynamic. We hand-select and vet every buyer who gets to bid on a practice — the way a doorman with a velvet rope lets in only the right people — and then run a private competitive bidding window inside that vetted group.

The filter is what creates the leverage.

Across the deals we’ve closed over the past four-plus years, the difference between direct-offer outcomes and competitive-process outcomes on the same practice has never been marginal. It has always been material.

Sometimes dramatically so.

The right time to engage a sell-side advisor is before you respond to any formal offer. If you’ve already received an offer, the right time is now.

Step 6: Evaluate the buyer, not just the bid

Price is the most visible variable in an acquisition offer. It is not the only one that determines whether the outcome was good.

In 2026, PE-backed consolidators typically operate on a 4- to 7-year hold cycle — they acquire, optimize, and eventually exit or recapitalize their portfolio. What happens to your practice, your staff, and your patients during that hold matters.

The integration philosophy, the degree to which clinical decisions remain local, the support structure the buyer provides, and the track record of how their other acquired practices have fared are all legitimate inputs to your evaluation.

They do not belong in place of price. But they belong alongside it.

The specific structure and terms of any buyer’s offer are negotiated case by case — the way to understand how any given buyer actually operates is to have them competing in a structured process where their full term sheets are on the table and you can compare them. Not from a single direct conversation where they control the information flow.

Step 7: Know the regulatory context in your state

The legislative environment around veterinary practice acquisitions is changing. New York’s proposed Assembly Bill 9042 — introduced September 2025 and under review again in January 2026, per Holland & Knight’s Q1 2026 healthcare consolidation recap — would require veterinary clinics to file notice with the state Attorney General before completing certain transactions, with a 90-day window for the AG to determine whether the acquisition is against the public interest.

That bill has not passed as of June 2026. But it signals a broader regulatory direction. Practices in states with active healthcare consolidation legislation should factor regulatory timelines into deal planning — a transaction that requires 60 to 90 days of state review on top of normal due diligence has different preparation requirements than one that doesn’t.

Your M&A counsel can confirm the applicable regulatory framework for your state. This is not a reason to avoid selling — it’s a reason to give yourself the planning runway to sell on your terms rather than a compressed timeline imposed by a buyer’s urgency.

---

What the current market actually looks like for unsolicited offers in 2026

One question I hear at every dinner where this comes up: is this a good time to be receiving unsolicited offers? The honest answer in 2026 is yes — but with clear-eyed context.

Capstone Partners‘ April 2026 data shows deal momentum building, with quality profitable assets still commanding premium valuations in the words of Tom Elliott, Capstone’s Managing Director. The 2025 period of relative restraint — when some PE-backed buyers pulled back to larger practices and tighter criteria — has given way to a healthier acquisition environment.

Buyers who were quiet are active again. That’s why the calls are coming.

What it does not mean is that a direct, single-bidder offer in the current environment reflects what a competitive process would produce. The buyers returning to the market are returning selectively.

They know the practices they want. And they know that approaching those practices directly — before anyone else has a chance to compete — is the way to get the most favorable pricing dynamics.

Understanding that dynamic is understanding why the playbook I’ve outlined above matters more, not less, when the market is active.

---

A comparison: direct offer vs competitive process for a veterinary practice

Factor	Direct single-buyer offer	Competitive process
Number of bidders	1	5 to 10+ qualified buyers
Buyer knows competition exists	No	Yes
Seller has leverage in negotiation	Low	High
Headline price	Buyer’s opening position	Market-clearing price
Terms (earnout, holdback, employment)	Buyer-favorable defaults	Negotiated with alternatives
Time to exclusivity	Immediate pressure	Seller controls timing
Post-process optionality	None — committed to one buyer	Full — seller chooses from competing bids
Regulatory awareness built in	Buyer’s counsel only	Seller’s counsel + advisor

The table captures the structural reality. Every advantage in the direct-offer column belongs to the buyer.

Every advantage in the competitive-process column belongs to you — but only if you run one.

---

What you actually need to do next

If you are reading this because you’ve already received an inquiry, three things matter more than anything else right now.

First: do not let urgency make the decision for you. The most common pressure tactic in a direct acquisition approach is artificial time urgency — “we’re making decisions by end of month” or “I have three other practices we’re considering.” That urgency reflects the buyer’s desire to prevent you from shopping the deal, not any real external constraint on their side.

Second: get your own valuation and your own advisor before you engage substantively with the buyer’s process. The moment you start producing financial documentation for a buyer without knowing what those numbers are worth in the full market, you are negotiating against yourself.

Third: understand that engaging a sell-side advisor does not mean you are committed to selling. Many owners I’ve worked with have started the conversation because a buyer approached, gotten clear on their practice’s value and the process, and chosen to wait 12 to 18 months before formally selling — with better financials, better documentation, and a plan.

Some of those have been our best outcomes. The process is information either way.

If you’re not ready to engage an advisor, at minimum: understand your practice’s valuation before you engage any buyer on price. And review what the current buyer pool looks like so you know the full range of buyers who might compete for a practice like yours — not just the one who called first.

For more on how the sale process actually works from engagement to closing, and what PE-backed buyers are currently paying, those guides walk through the full picture.

For practices that have received an earnout-heavy offer, our piece on earnouts and rollover equity structures breaks down what those terms actually mean to your net proceeds.

Get a Free Practice Value Estimate →

We review the practice, benchmark it against current market multiples, and give you an honest picture of what a competitive process would likely produce. No commitment to sell required.

If the timing isn’t right, we’ll tell you what would move the number and when to come back.

Our engagement model is success-based — we only get paid when a deal closes, and only out of the value created above what you would have realized without us. That alignment matters: we have no incentive to rush you into a transaction that isn’t in your interest.

---

Frequently asked questions

What should I do when I receive an unsolicited offer for my veterinary practice in 2026?

Take the introductory call — but sign nothing. The first step is to get an independent valuation of your practice so you know whether the offer reflects market value.

Then engage a sell-side advisor to run a competitive process with multiple qualified buyers before you commit to any exclusivity period. A direct offer from one buyer is almost never the best outcome available to your practice.

Is an unsolicited offer for a veterinary practice a good starting point for a sale?

It can be a useful signal that your practice is acquisition-ready and attracting serious buyers. But a direct, single-bidder offer is almost always lower than what the same practice would clear through a competitive process with multiple qualified bidders.

Use the unsolicited offer as confirmation that demand exists — not as the final number.

What is an LOI exclusivity clause and why does it matter to vet practice sellers in 2026?

An LOI exclusivity clause is a legally binding provision that prevents you from speaking with or entertaining offers from other buyers for a defined period — typically 60 to 90 days. It is usually the only binding part of the Letter of Intent.

Once you sign it, all competitive leverage disappears until the period expires. Signing exclusivity before running a competitive process is the single most costly mistake sellers make.

How much more can a competitive process return compared to a direct unsolicited offer for a veterinary practice?

The gap between a direct, single-bidder offer and a competitive-process outcome on the same practice is consistently meaningful — often running into seven figures on any substantial practice. Capstone Partners‘ April 2026 Pet Sector M&A Update confirms that quality, profitable assets still command premium valuations when properly brought to market.

The difference is not the practice — it is the process.

How do I know if an unsolicited offer for my veterinary practice is fair?

You need an independent valuation based on your normalized EBITDA — what your practice earns in operating profit after stripping personal expenses run through the practice — and current market multiples for practices of your size, region, and buyer type. Without that baseline, you cannot judge whether the offer is at market, below it, or what a competitive process would produce.

Can I negotiate an unsolicited offer from a PE-backed consolidator without running a competitive process?

You can negotiate, but you are negotiating without leverage. A buyer who knows they are the only bidder knows your best alternative is to walk away — which most sellers don’t do.

Running a competitive process, or at minimum letting the buyer know you are exploring the market, fundamentally changes the negotiation dynamic. Leverage comes from alternatives, and alternatives come from competition.

What are the key terms to negotiate beyond price in a veterinary practice acquisition in 2026?

Beyond the headline price, focus on: cash at closing versus earnout split; earnout triggers and the specific metrics they are tied to; holdback percentage and release timeline; employment agreement duration and compensation; non-compete scope and geography; working capital peg; and rollover equity percentage if applicable. Each of these can move the effective value of the deal by hundreds of thousands of dollars or more.

Does receiving an unsolicited offer mean I have to sell my veterinary practice now?

No. Receiving an offer is not a commitment to sell.

You can engage with a buyer’s inquiry, learn what the market thinks your practice is worth, and still decide the timing is wrong. Many owners use the experience to understand where they stand — then prepare more deliberately and sell 12 to 18 months later, with better financial documentation and at a time of their choosing rather than the buyer’s.

---

Sources

Industry M&A research and valuation data

1. Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com

2. Mergers & Acquisitions Magazine. “M&A Animal Attraction.” themiddlemarket.com

Veterinary practice operations, benchmarks, and profession data

3. American Animal Hospital Association (AAHA). “Unlocking Success: A Guide to Selling Your Veterinary Practice to a VSO/Consolidator/Corporate Owner.” December 2024. aaha.org

4. AAHA Trends Magazine. “Practice Ownership Exit (and Entry) Strategies.” July 2024. aaha.org

5. dvm360. “8 Essential Steps in a Veterinary Practice Sale.” dvm360.com

6. dvm360. “What Advisors Bring to Your Veterinary Hospital Sale.” dvm360.com

7. Today’s Veterinary Business. “Seal the Deal.” todaysveterinarybusiness.com

Legal and regulatory analysis

8. Holland & Knight. “Q1 Recap on Proposed Legislation Affecting Healthcare Consolidation.” March 2026. hklaw.com

9. Holland & Knight. “Up Next: Vet Clinic Acquisitions Targeted for Review and Approval in New York.” September 2025. hklaw.com

10. Paul Hastings LLP. “Considerations For Private Equity After FTC Vet Clinic Deal.” paulhastings.com

11. Mahan Law. “Letter of Intent: Binding or Non-Binding.” mahanlaw.com

12. Mintz. “No ‘Paws’ in Oversight: Will New York’s Proposed Veterinary Transaction Review Law Take Effect in 2026?” January 2026. mintz.com

Public company disclosures and PE activity

13. American Veterinary Medical Association (AVMA). “NVA Splits Into Two Businesses, May Go Public in Next Few Years.” avma.org

14. Federal Trade Commission. “FTC Takes Second Action Against JAB Consumer Partners.” June 2022. ftc.gov